SCHEMBL1328632

SCHEMBL1328632

O=C(O)C1=CC[CH]C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4056562 0.79
SCHEMBL28199911 0.79
SCHEMBL8176615 0.75
SCHEMBL6636579 0.71 HPGD (0.38)
SCHEMBL27990458 0.71
SCHEMBL6218786 0.70 HPGD (0.46)
SCHEMBL21843292 0.70
SCHEMBL574514 0.70
SCHEMBL28126272 0.69
SCHEMBL6634977 0.68 SIGMAR1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013204-B1 2-AMINOPYRIDINE ANALOGS AS GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC (US) 2015-02-18 EP disclosed
EP-2543667-B1 A method of preparing 2-aminopyridine analogs as glucokinase activators ARRAY BIOPHARMA INC (US) 2015-01-28 EP disclosed
US-8883828-B2 2-aminopyridine analogs as glucokinase activators ARRAY BIOPHARMA INC. (US) 2014-11-11 US disclosed
EP-2732002-A1 OIL EMULSIFICATION AND POLYCYCLIC AROMATIC HYDROCARBON ADSORPTION USING FINE PARTICLES AS DISPERSANTS Cabot Corporation (US) 2014-05-21 EP disclosed
EP-2543667-A9 2-aminopyridine analogs as glucokinase activators Array Biopharma, Inc. (US) 2013-08-21 EP disclosed
US-20130065901-A1 2-AMINOPYRIDINE ANALOGS AS GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2013-03-14 US disclosed
WO-2013009744-A1 OIL EMULSIFICATION AND POLYCYCLIC AROMATIC HYDROCARBON ADSORPTION USING FINE PARTICLES AS DISPERSANTS CABOT CORPORATION (US) 2013-01-17 WO disclosed
US-8354540-B2 2-aminopyridine analogs as glucokinase activators ARRAY BIOPHARMA INC. (US) 2013-01-15 US disclosed
US-20110281874-A1 2-AMINOPYRIDINE ANALOGS AS GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2011-11-17 US disclosed
US-8022223-B2 2-aminopyridine analogs as glucokinase activators ARRAY BIOPHARMA, INC. (US) 2011-09-20 US disclosed
US-20090156603-A1 2-AMINOPYRIDINE ANALOGS AS GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2009-06-18 US disclosed
EP-2013204-A2 2-AMINOPYRIDINE ANALOGS AS GLUCOKINASE ACTIVATORS Array Biopharma, Inc. (US) 2009-01-14 EP disclosed
WO-2007117381-A9 2 -AMINOPYRIDINE ANALOGS AS GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC (US) 2008-03-27 WO disclosed
WO-2007117381-A2 2 -AMINOPYRIDINE ANALOGS AS GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2007-10-18 WO disclosed
US-20020037485-A1 Method of preparing ultrathin light-sensitive tabular grain emulsions rich in silver bromide AGFA HEALTHCARE (BE) 2002-03-28 US disclosed
EP-0970073-A4 PROCESS FOR PREPARING EPROSARTAN SMITHKLINE BEECHAM CORP (US) 2001-01-24 EP disclosed
EP-0970073-A1 PROCESS FOR PREPARING EPROSARTAN SMITHKLINE BEECHAM CORPORATION (US) 2000-01-12 EP disclosed
WO-1998035963-A1 PROCESS FOR PREPARING EPROSARTAN SMITHKLINE BEECHAM CORPORATION (US) 1998-08-20 WO disclosed
EP-0189305-B1 PEPTIDE DERIVATIVES ICI AMERICAS INC. (US) 1992-07-29 EP disclosed
EP-0189305-A2 Peptide derivatives ICI AMERICAS INC. (US) 1986-07-30 EP disclosed